HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20240827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Shir Bergson und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Tel Aviv Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Simplex. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Austrian Science Fund, Paracelsus Medical University Salzburg.
Abstract (Originalsprache)
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Tel Aviv Medical Center, Tel Aviv, Israel.
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Internal Medicine D, Tel Aviv Medical Center, Tel Aviv, Israel.
- Faculty of Life Sciences, School of Neurobiology, Biochemistry and Biophysics, Tel Aviv University, Tel Aviv, Israel.
- Department of Dermatology and Allergology, EB House Austria, Research Program for Molecular Therapy of Genodermatoses, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
- The Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
ORCID-Profile: Shir Bergson, Ofer Sarig, Moshe Giladi, Janan Mohamad, Mariana Mogezel-Salem, Karina Smorodinsky-Atias, Ofir Sade, Bar Manori, Sari Assaf, Kiril Malovitski, Yarden Feller, Mor Pavlovsky, Stefan Hainzl, Thomas Kocher, Julia I Hummel, Noy Eretz Kdosha, Lubna Gazi Khair, Roland Zauner, Josefina Pinon Hofbauer, Ruby Shalom-Feuerstein, Verena Wally, Ulrich Koller, Liat Samuelov, Yoni Haitin, Uri Ashery, Rotem Rubinstein, Eli Sprecher
Förderung
- Israel Science Foundation
- Austrian Science Fund
- Paracelsus Medical University Salzburg
- Israel Ministry of Science Technology
- DEBRA International
Zitieren
APA
Bergson, S., Sarig, O., Giladi, M., Mohamad, J., Mogezel-Salem, M., Smorodinsky-Atias, K., Sade, O., Manori, B., Assaf, S., Malovitski, K., Feller, Y., Pavlovsky, M., Hainzl, S., Kocher, T., Hummel, J. I., Eretz Kdosha, N., Khair, L. G., Zauner, R., Pinon Hofbauer, J., …, & Sprecher, E. (2025). HMCN1 variants aggravate epidermolysis bullosa simplex phenotype. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240827
Vancouver
Bergson S, Sarig O, Giladi M, Mohamad J, Mogezel-Salem M, Smorodinsky-Atias K, et al. HMCN1 variants aggravate epidermolysis bullosa simplex phenotype. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20240827
BibTeX
@article{Bergson2025,
author = {Bergson, Shir and Sarig, Ofer and Giladi, Moshe and Mohamad, Janan and Mogezel-Salem, Mariana and Smorodinsky-Atias, Karina and Sade, Ofir and Manori, Bar and Assaf, Sari and Malovitski, Kiril and Feller, Yarden and Pavlovsky, Mor and Hainzl, Stefan and Kocher, Thomas and Hummel, Julia I and Eretz Kdosha, Noy and Khair, Lubna Gazi and Zauner, Roland and Pinon Hofbauer, Josefina and Shalom-Feuerstein, Ruby and Wally, Verena and Koller, Ulrich and Samuelov, Liat and Haitin, Yoni and Ashery, Uri and Rubinstein, Rotem and Sprecher, Eli},
title = {HMCN1 variants aggravate epidermolysis bullosa simplex phenotype},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20240827}
}
EUVIMED